drugset / Trial / NCT06111183

Evaluation of AUP12602-C as New Topical Treatment for DFUs (DIAMEND STUDY)

NCT06111183 ↗

Phase 2 Completed 64 enrolled Aurealis Oy
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a phase 2 study performed in diabetic foot ulcer (DFU) patients with chronic non-healing, neuro-ischemic wounds to investigate the safety, tolerability and efficacy of AUP1602-C.

Timeline

Start
2023-07-21
Primary completion
2025-11-28
Completion
2025-11-28

Drugs

EvaluationDrugModalityDoseRoute
Subject AUP1602-C Unknown 2.5e+08 unknown Topical

Indications